MedTrace Logo

Hyaluronan-enriched Embryo Transfer Medium for Frozen-thawed Embryo Transfer

NCT02725827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 550

Last updated 2019-01-25

No results posted yet for this study

Summary

This is a randomized-controlled trial evaluating the effect of the use of hyaluronan (HA)-enriched embryo transfer medium on the live birth rate in women undergoing frozen-thawed embryo transfer. For half of the women, hyaluronan-enriched medium will be used as embryo transfer medium. For the other half of women, a control will be used.

Conditions

  • In Vitro Fertilization
  • Subfertility

Interventions

OTHER

EmbryoGlue (Vitrolife)

A hyaluronan-enriched embryo transfer medium

OTHER

Control medium

The usual embryo transfer medium used in the study centres.

Sponsors & Collaborators

  • Kwong Wah Hospital

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Shuk Fei Sofie Yung, MBBS · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02725827 on ClinicalTrials.gov